Higher dose of Arena Pharma's bowel disease drug meets study goal [Reuters (UK)]
Arena Pharmaceuticals, Inc. (ARNA)
Last arena pharmaceuticals, inc. earnings: 2/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
invest.arenapharm.com/investor-relations
Company Research
Source: Reuters
Higher dose of Arena Pharma's bowel disease drug meets study goal | Reuters Reuters Staff 2 Min Read (Reuters) - Arena Pharmaceuticals Inc said on Monday a higher dose of its experimental drug succeeded in improving symptoms associated with ulcerative colitis, a chronic bowel disease, in a mid-stage study. The U.S.-based company said it planned to move the drug, etrasimod, to late-stage trials based on the data. However, the company said a lower dose did not significantly improve the disease symptoms on a scale measuring severity that included stool frequency, rectal bleeding and findings on endoscopy. The company is banking on etrasimod, along with its pulmonary arterial hypertension drug, after shifting its focus away from its weight-loss treatment due to underwhelming sales. Arena sold the global commercialization rights to the weight-loss drug, Belviq, to Japanese drugmaker Eisai Co Ltd early last year. Significantly more patients in etrasimod’s higher dosage, 2 mg group, achieved
Show less
Read more
Impact Snapshot
Event Time:
ARNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARNA alerts
High impacting Arena Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics